Gabapentin Capsule
Product Images NDC 76420-014

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

The given text seems to be a formula for calculating the estimated glomerular filtration rate (eGFR) using the patient's age, weight, and serum creatinine level. However, the formula seems incomplete and it's difficult to interpret without the missing values.*

FDA Label Image

1 (Image 10)

FDA Label Image

1 (Image 11)

FDA Label Image

1 (Image 13)

This is a description of a medication called Gabapentin Capsules, USP 100mg. It is packaged by Enovachem in Torrance, CA and distributed by Actavis Pharma, Inc. The medication comes in a bottle of 30 capsules with the National Drug Code (NDC) of 76420-014-30 and a drug status of RX. The capsules are white/light brown with the logo 685(17)000000 on them. They should be kept out of reach of children and stored at a temperature between 20-25°C (48-77°F). The lot number is 0000000 with an expiration date of 0010010000 1910000000 and Batch Number XO000XX (21)000000.*

FDA Label Image

1 (Image 14)

The text describes the packaging of Gabapentin Capsules in different quantities and variations of yellow/light-brown color and a logo with 300mg strength. The packaging is distributed by Actavis Pharma, Inc. The details of the lot number, batch number, and expiration date are mentioned, and the drug status is RX, indicating that it can only be purchased with a prescription. The text also includes cautionary statements, including the prohibition of dispensing without a prescription and keeping it out of reach of children. The details about storage temperatures are also mentioned.*

FDA Label Image

1 (Image 2)

FDA Label Image

1 (Image 3)

FDA Label Image

1 (Image 5)

FDA Label Image

1 (Image 6)

The text describes a chart or table showing the mean pain score for a study involving a dose titration period followed by a fixed dose period of four weeks. Two treatments are compared: a placebo and gabapentin at a dosage of 3600 mg/day. The chart or table includes a baseline measurement and data for several weeks but the specific details are not provided.*

FDA Label Image

2 (Image 7)

This appears to be a chart or graph showing the mean pain score (which is 0) for various periods and doses of a medication called Gabapentin. The chart includes a 4-week fixed dose period and a titration period and shows dosages of 1800mg/day and 2400mg/day. There is no additional context or information available.*

FDA Label Image

3 (Image 8)

FDA Label Image

4 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.